subject area of
- A Double-Blind, Randomized Controlled Trial of the Prevention of Clinically Important Venous Thromboembolism After Isolated Lower Leg Fractures Journal Articles
- A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions Journal Articles
- A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I Journal Articles
- Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial Journal Articles
- Anti-Xa effect of a low molecular weight heparin (dalteparin) does not accumulate in extended duration therapy for venous thromboembolism in cancer patients Journal Articles
- Anticoagulant Effect at the Time of Epidural Catheter Removal in Patients Receiving Twice-daily or Once-daily Low-molecular-weight Heparin and Continuous Epidural Analgesia after Orthopedic Surgery Journal Articles
- Anticoagulant response after dalteparin overdose Journal Articles
- Anticoagulants in acute coronary syndromes Journal Articles
- Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Journal Articles
- Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Journal Articles
- Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Journal Articles
- Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer Journal Articles
- Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer Journal Articles
- Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty Journal Articles
- Can we differentiate the low-molecular-weight heparins? Journal Articles
- Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study Journal Articles
- Clinical implications of incidental venous thromboembolism in cancer patients Journal Articles
- Clinical trials of deep vein thrombosis prophylaxis in medical patients Journal Articles
- Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery Disease Journal Articles
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) Journal Articles
- Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism Journal Articles
- Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients Journal Articles
- Cost-effectiveness of Dalteparin vs Unfractionated Heparin for the Prevention of Venous Thromboembolism in Critically Ill Patients Journal Articles
- Dalteparin Compared with an Oral Anticoagulant for Thromboprophylaxis in Patients with Cancer Journal Articles
- Dalteparin Low Molecular Weight Heparin (LMWH) in ovarian cancer: A phase II randomized study Journal Articles
- Dalteparin and Heparin-Induced Thrombocytopenia Journal Articles
- Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial Journal Articles
- Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency Journal Articles
- Dalteparin versus Unfractionated Heparin in Critically Ill Patients Journal Articles
- Dalteparin versus Warfarin for the Prevention of Recurrent Venous Thromboembolic Events in Cancer Patients Journal Articles
- Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial Journal Articles
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism Journal Articles
- Edoxaban for treatment of venous thromboembolism in patients with cancer Journal Articles
- Efficacy and Safety of Fixed Low-Dose Dalteparin in Preventing Venous Thromboembolism Among Obese or Elderly Hospitalized Patients Journal Articles
- Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis Journal Articles
- Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post‐hoc analysis of the Hokusai‐VTE Cancer study Journal Articles
- Fragmin in Unstable Angina Pectoris or in Non-Q-Wave Acute Myocardial Infarction (the FRIC Study) Journal Articles
- Heparin-Induced Thrombocytopenia in Medical Surgical Critical Illness Journal Articles
- High incidence of in-hospital pulmonary embolism following joint arthroplasty with dalteparin prophylaxis Journal Articles
- Low Molecular Weight Heparin Administered once versus twice Daily in Patients with Venous Thromboembolism Journal Articles
- Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS) Journal Articles
- Low molecular weight heparins in the treatment of unstable angina. Journal Articles
- Low-Molecular-Weight Heparin Did Not Differ from Placebo in Preventing Clinically Important Deep Venous Thrombosis After Surgical Repair of Leg Fracture Journal Articles
- Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin in Close Proximity to Surgery vs Warfarin in Hip Arthroplasty Patients Journal Articles
- Low-Molecular-Weight Heparin for Anticoagulation During Continuous Venovenous Hemofiltration—Reply Journal Articles
- Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer Journal Articles
- Low-molecular-weight heparin for anticougulation during continuous venovenous hemofiltration - Reply Journal Articles
- Management of Severe Mitral Stenosis During Pregnancy Journal Articles
- Management of intentional overdose of low-molecular-weight heparin Journal Articles
- Management of unstable coronary-artery disease Journal Articles
- Management of venous thromboembolism in patients with cancer: role of dalteparin Journal Articles
- Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement Journal Articles
- PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma Journal Articles
- PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan Journal Articles
- Physicians declining patient enrollment in a critical care trial: a case study in thromboprophylaxis Journal Articles
- Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial Journal Articles
- Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: Analysis of the BRIDGE trial Journal Articles
- Preventing Venous Thromboembolism in Critically Ill Patients Journal Articles
- Prophylaxis Against Deep Vein Thrombosis in Critically Ill Patients With Severe Renal Insufficiency With the Low-Molecular-Weight Heparin Dalteparin<subtitle>An Assessment of Safety and Pharmacodynamics: The DIRECT Study</subtitle> Journal Articles
- Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboembolism Journal Articles
- Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients Journal Articles
- Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis Journal Articles
- Safety of dalteparin for the prophylaxis of venous thromboembolism in elderly medical patients with renal insufficiency: a pilot study. Journal Articles
- Sex differences in thromboprophylaxis of the critically ill: a secondary analysis of a randomized trial Journal Articles
- Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin Journal Articles
- Therapy of unstable angina with the low molecular weight heparins Journal Articles
- Thromboprophylaxis with dalteparin in medical patients: which patients benefit? Journal Articles
- Treatment of Proximal Deep Vein Thrombosis With a Novel Synthetic Compound (SR90107A/ORG31540) With Pure Anti–Factor Xa Activity Journal Articles
- Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study Journal Articles
- Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin prophylaxis: prevalence, incidence and risk factors Journal Articles
- Video laparoscopic surgery: is out‐of‐hospital thromboprophylaxis necessary? Journal Articles
- What’s New for DVT Prophylaxis for the Medically Ill Journal Articles